ducovest

ERX:ARCA-Direxion Energy Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 57.97

Change

+1.01 (+1.77)%

Market Cap

USD 0.44B

Volume

0.46M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the Energy Select Sector Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the Energy Select Sector Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is provided by S&P Dow Jones Indices (the "index provider") and includes domestic companies from the energy sector which includes the following industries: oil, gas and consumable fuels; and energy equipment and services. The fund is non-diversified.

Company Website : http://www.direxioninvestments.com/

Currency: USD

Country : USA

Inception Date: 06/11/2008

Primary Benchmark: S&P Energy Select Sector TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.96%

Management Expense Ratio: 1.08 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 5.85 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-03 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

 USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

 USD 7.96B
QLD ProShares Ultra QQQ 0.95 %

N/A

 USD 7.84B
SSO ProShares Ultra S&P500 0.90 %

N/A

 USD 5.60B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

 USD 4.27B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

 USD 3.43B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

 USD 1.61B
USD ProShares Ultra Semiconductors 0.95 %

N/A

 USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

 USD 0.91B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

 USD 0.82B

ETFs Containing ERX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.08% 78% C+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.08% 78% C+ 90% A-
Trailing 12 Months  
Capital Gain 0.54% 27% F 37% F
Dividend Return 2.29% 82% B 36% F
Total Return 2.83% 27% F 30% F
Trailing 5 Years  
Capital Gain -67.41% 23% F 6% D-
Dividend Return 3.14% 50% F 8% B-
Total Return -64.28% 23% F 5% F
Average Annual (5 Year Horizon)  
Capital Gain 83.22% 85% B 96% N/A
Dividend Return 86.56% 87% B+ 96% N/A
Total Return 3.34% 92% A 68% D+
Risk Return Profile  
Volatility (Standard Deviation) 259.91% 18% F 4% F
Risk Adjusted Return 33.30% 55% F 48% F
Market Capitalization 0.44B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.